Chelsea Therapeutics International Ltd (NASDAQ:CHTP)

Data as of Apr 17
 -0.03 / -0.63%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders. The company product includes NORTHERA™. Chelsea Therapeutics International was founded by Simon Pedder on June 17, 2005 and is headquartered in Charlotte, NC.

Contact Information

Chelsea Therapeutics International Ltd.
3530 Toringdon Way
Charlotte North Carolina 28277
P:(704) 341-1516
Investor Relations:



Other institutional23.61%
Individual stakeholders22.12%
Mutual fund holders13.44%

Top Executives

Joseph G. OlivetoPresident, Chief Executive Officer & Director
J. Nick RiehleChief Financial Officer & VP-Administration
L. Arthur HewittChief Scientific Officer & Vice President
William D. SchwietermanChief Medical Officer & Vice President
Michael J. RobertsVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.